Zhou Sijie, Mofatteh Mohammad, Chen Zhikai, Tang Jinyan, Ma Jicai, Ouyang Ziqi, Wang Jian, Luo Senrong, He Yuankang, Li Zhenzhang, Lai Yuzheng, Liao Xuxing
Department of Surgery of Cerebrovascular Diseases, First People's Hospital of Foshan, Foshan, China.
School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, United Kingdom.
Front Neurol. 2025 Mar 27;16:1489714. doi: 10.3389/fneur.2025.1489714. eCollection 2025.
Stroke is a leading cause of morbidity and mortality worldwide. Endovascular therapy (EVT) has been established as a gold standard option to treat acute ischemic stroke (AIS) patients with large vessel occlusion (LVO) presenting within 6 h of symptom onset. However, there is a paucity of information regarding patient outcome and mortality in patients presenting in late time window within 6 to 24 h. In this study, we aimed to assess for predictors of outcomes in late window stroke patients following EVT.
We analyzed data from 202 patients treated with EVT from four comprehensive stroke centers. All patients were above 18 years of age and had symptoms onset of 6-24 h. mRS of 0-2 after three months was defined as favorable outcome.
Patients with favorable outcome had lower median age ( 0.003), lower pre-EVT National Institute of Health Stroke Scale (NIHSS) score ( 0.000), lower diabetes mellitus ( 0.041), stroke history ( 0.041), parenchymal hematoma (PH) ( 0.000) and fewer attempts to achieve successful recanalization ( 0.001). Multivariate regression analysis found age ( 0.007), diabetes mellitus ( 0.022), successful recanalization (mTICI≥2b) ( 0.006), NIHSS at onset ( 0.000), and PH1 + PH2 Heidelberg bleeding classification ( 0.009) as predictors of functional outcome.
Age, diabetes mellitus history, baseline NIHSS score, successful recanalization, and PH are predictors of 90-day functional outcome of late-window ischemic stroke patients undergoing EVT.
中风是全球发病和死亡的主要原因。血管内治疗(EVT)已被确立为治疗症状发作6小时内出现大血管闭塞(LVO)的急性缺血性中风(AIS)患者的金标准选择。然而,关于在6至24小时的晚期时间窗内就诊的患者的预后和死亡率的信息很少。在本研究中,我们旨在评估晚期时间窗中风患者接受EVT后的预后预测因素。
我们分析了来自四个综合中风中心接受EVT治疗的202例患者的数据。所有患者年龄均在18岁以上,症状发作时间为6 - 24小时。三个月后改良Rankin量表(mRS)评分为0 - 2被定义为良好预后。
预后良好的患者年龄中位数较低(0.003),EVT前美国国立卫生研究院卒中量表(NIHSS)评分较低(0.000),糖尿病(0.041)、中风病史(0.041)、脑实质血肿(PH)(0.000)较少,成功再通的尝试次数较少(0.001)。多变量回归分析发现年龄(0.007)、糖尿病(0.022)、成功再通(mTICI≥2b)(0.006)、发病时的NIHSS评分(0.000)以及PH1 + PH2海德堡出血分类(0.009)是功能预后的预测因素。
年龄、糖尿病史、基线NIHSS评分、成功再通和PH是晚期时间窗缺血性中风患者接受EVT后90天功能预后的预测因素。